KINE WILLIAMS: Open Payments
NPI 1689266215 · SUNRISE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,203 in 155 payments from 34 companies in 2025. Trend: 2023 $908 · 2024 $1,656 · 2025 $3,203
Food & beverage: $3,203
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $443 |
| AstraZeneca Pharmaceuticals LP | 15 | $359 |
| Novartis Pharmaceuticals Corporation | 19 | $238 |
| Daiichi Sankyo Inc. | 8 | $210 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $187 |
| PFIZER INC. | 8 | $179 |
| TerSera Therapeutics LLC | 7 | $172 |
| Janssen Biotech, Inc. | 9 | $161 |
| Incyte Corporation | 7 | $148 |
| Merck Sharp & Dohme LLC | 9 | $136 |
Products named: JEMPERLI, ENHERTU, Zoladex, MONJUVI, DATROWAY, Fabhalta, ZEJULA, KISQALI.
Industry payments across FL — which companies pay providers there.
